Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993.

Details

Ressource 1Download: serval:BIB_14323.P001 (499.24 [Ko])
State: Public
Version: author
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_14323
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993.
Journal
Annals of Oncology
Author(s)
Levi F., Randimbison L., Van-Cong Te, Franceschi S., La Vecchia C.
ISSN
0923-7534
Publication state
Published
Issued date
2000
Volume
11
Number
8
Pages
957-963
Language
english
Notes
Publication types: Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
Abstract
BACKGROUND: Analysis of trends in cancer survival in defined well surveilled populations can provide useful indications on advancements in cancer management and treatment. PATIENTS AND METHODS: Survival rates from the Vaud Cancer Registry were computed for 31,158 cases registered in 1984-1993, and compared with those registered in 1974-1978 and 1979-1983. RESULTS: A systematic, albeit generally moderate, tendency towards increasing five-year relative survival was observed for both sexes and most major cancer sites, including oral cavity and pharynx (0.38-0.43). stomach (0.21-0.26), colon (0.49-0.55), rectum (0.45-0.51), lung (0.08-0.12), skin melanoma (0.67-0.89), female breast (0.67-0.80), endometrium (0.72-0.84), ovary (0.28-0.37). prostate (0.44-0.66), testis (0.73-0.96), bladder (0.31-0.50), kidney and renal pelvis (0.41-0.59), thyroid (0.73-0.81), non-Hodgkin's lymphomas (0.37-0.63), Hodgkin's disease (0.61-0.81), and leukaemias (0.27-0.39). Survival for all cancers and both sexes combined, rose from 0.51 0.64 (0.57 for males, 0.71- for females). No appreciable change in survival was observed for cancers of oesophagus, liver, gallbladder, pancreas, larynx, cervix uteri, brain, multiple myeloma, as well as unidentified or unknown origin neoplasms. CONCLUSIONS: Survival estimates for most cancer sites are comparable to the US SEER dataset, and their pattern of trends are discussed in terms of improved diagnosis and treatment for various neoplasms.
Keywords
Adult, Aged, Female, Humans, Male, Middle Aged, Neoplasms/mortality, Neoplasms/pathology, Population Surveillance, Prognosis, Registries, Retrospective Studies, SEER Program, Sex Factors, Survival Analysis, Switzerland/epidemiology
Pubmed
Web of science
Open Access
Yes
Create date
19/11/2007 12:06
Last modification date
25/09/2019 6:08
Usage data